1537 Effectiveness of Melatonin in Treating Sleep Problems in Children - Parent Satisfaction Survey
Abstract
Background and Aim Melatonin is not licensed for children in UK. Limited evidence is available about its efficacy and safety. We assessed parents’ satisfaction with melatonin for treatment of sleep problems in children. Methods 27 children who were prescribed melatonin by community paediatricians at Bedford, UK were randomly selected. Structured questionnaire was given to their parents. Results Parents’ overall assessment of response to melatonin treatment - Good (63%), Average (33%), Poor (4%). Analysis of age group of children with good response. 1–5 years (3 out of 3 children i.e. 100%), 6–10 years (7/12 i.e. 58%), 11–16 years (7/10 i.e. 70%), Over 16 years (0/2 i.e. 0%). Effect on sleep when melatonin was stopped (in 18 children) - worsening (72%), same (28%), improvement (0%). All the children had associated problems - 81% behavioural (autism, ADHD), 19% structural/chromosomal. 41% were in mainstream school, 55% special need school and 4% left school. Improvement in behaviour secondary to improvement in sleep - yes (26%), No (74%). Improvement in quality of life of parents secondary to fewer interruptions to their sleep - Yes (77%), No (23%). Only 1 child had side effects including headache, confusion and tiredness while taking melatonin. He was on high dose of 10 mg/day. Conclusion Most parents reported improvement in sleep of their children after being started on melatonin. Also majority reported better quality of life due to less interruption to their sleep.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.